Funding, health professional shortage could prevent South Africa from reaching 2011 ARV target, Health Minister says

NewsGuard 100/100 Score

South Africa's shortage of health professionals combined with a budget shortfall of over $130 million for the government's HIV programs could keep the country from reaching its goal of providing 80 percent of the people living with HIV/AIDS in need of treatment with antiretroviral drugs (ARVs) by 2011, South African Health Minister Aaron Motsoaledi said on Tuesday, Reuters reports. Motsoaledi said of the funding, "We have discussed it with Treasury, calculated the costs and I have already met international funders. We are waiting and hoping that there is no chance of the actual shortfall happening."

According to Motsoaledi, an estimated 700,000 HIV-positive South African's currently receive ARVs. "Unfortunately it is only 50 percent of the number that has been targeted," he told Reuters. The article examines the factors contributing to the shortage of health professionals in South Africa, including trained professionals leaving the country for positions that offer higher pay and better conditions, and the low number of doctors being trained in the country compared to those needed annually.

According to Reuters, "[d]espite his overstretched budget, Motsoaledi is exploring providing ARVs to patients" earlier than when currently dispensed by public hospitals. "Waiting for people to go to a CD4 count of 200 is too low too late, maybe we should start them at 350," Motsoaledi said (Govender, 9/15).


Kaiser Health NewsThis article was reprinted from khn.org with permission from the Henry J. Kaiser Family Foundation. Kaiser Health News, an editorially independent news service, is a program of the Kaiser Family Foundation, a nonpartisan health care policy research organization unaffiliated with Kaiser Permanente.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
New research sheds light on how GLP-1 obesity drugs may change food cravings